Bionano Genomics Inc [BNGO] stock is trading at $1.81, up 4.02%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The BNGO shares have gain 17.53% over the last week, with a monthly amount drifted -3.21%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Bionano Genomics Inc [NASDAQ: BNGO] stock has seen the most recent analyst activity on November 15, 2024, when Ladenburg Thalmann downgraded its rating to a Neutral. Previously, BTIG Research downgraded its rating to Neutral on September 10, 2024. On January 05, 2023, Scotiabank initiated with a Sector Outperform rating and assigned a price target of $4 on the stock. BTIG Research started tracking with a Buy rating for this stock on June 16, 2021, and assigned it a price target of $10. In a note dated September 24, 2020, Ladenburg Thalmann initiated an Buy rating and provided a target price of $1.25 on this stock.
Bionano Genomics Inc [BNGO] stock has fluctuated between $1.45 and $22.80 over the past year. Currently, Wall Street analysts expect the stock to reach $46.5 within the next 12 months. Bionano Genomics Inc [NASDAQ: BNGO] shares were valued at $1.81 at the most recent close of the market. An investor can expect a potential return of 2469.06% based on the average BNGO price forecast.
Analyzing the BNGO fundamentals
Bionano Genomics Inc [NASDAQ:BNGO] reported sales of 28.72M for the trailing twelve months, which represents a growth of 21.31%. Gross Profit Margin for this corporation currently stands at 0.47% with Operating Profit Margin at -1.28%, Pretax Profit Margin comes in at -1.34%, and Net Profit Margin reading is -1.34%. To continue investigating profitability, this company’s Return on Assets is posted at -0.49, Equity is -0.86 and Total Capital is -0.66. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.15.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.6967 points at the first support level, and at 1.5833 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.8767, and for the 2nd resistance point, it is at 1.9433.
Ratios To Look Out For
For context, Bionano Genomics Inc’s Current Ratio is 2.12. In addition, the Quick Ratio stands at 1.82 and the Cash Ratio stands at 0.13. Considering the valuation of this stock, the price to sales ratio is 0.64, the price to book ratio is 0.35.
